Analysis of marker assoriated with iron and inflammation in allogeneic cell transplantation: multicenter prospecitve study

Analysis of marker assoriated with iron and inflammation in allogeneic cell transplantation: multicenter prospecitve study - II-HCT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013506

Enrollment

140

Registered

2014-03-25

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)age more than 16 year old (2)First allogeneic cell transplantaion (3)acute leukemia, myelodysplastic syndrome, aplastic anemia, chronic leukemia, adult T-cell leukemia/lymphoma, malicnant lynphoma, multiple myeloma (4)informed consent

Exclusion criteria

Exclusion criteria: (1)history of allogeneic cell transplantation (2) decised unsuitable by associated doctor

Design outcomes

Primary

Measure	Time frame
overall survival at 2 year according to makers	—

Secondary

Measure	Time frame
(1)disease-free survival, non-relapse mortality, and relapse at 2 year according to makers (2)corelation between ferritin and other markers (3)relation between markers and transplant-related complications	—

Countries

Japan

Contacts

Public ContactTakayoshi Tachibana

Yokohama City University Internal medicine and clinical immunology

tcbnt@yokohama-cu.ac.jp045-787-2800

Outcome results